Experience
Vance Street Capital Partners With System Seals
December 9, 2024
Cooley advised Vance Street Capital, a Los Angeles-based middle-market private equity firm that invests in highly engineered solutions businesses across the industrial technology, medical, life sciences, aerospace and defense sectors, on its acquisition of System Seals, a designer and manufacturer of custom fluid seals for various industrial applications.
Related contacts
Related Practices & Industries
Poseida Therapeutics Announces Agreement to Be Acquired by Roche for up to $1.5 Billion
November 26, 2024
Cooley advised Poseida Therapeutics, a clinical-stage allogeneic cell therapy and genetic medicines company advancing differentiated nonviral treatments for patients with cancer, autoimmune and rare diseases, on its merger agreement to be acquired by Roche at a price of $9 per share in cash at closing, plus a non-tradable contingent value right to receive up to an aggregate of $4 per share in cash, payable upon achievement of specified milestones. The price payable at closing represents a total equity value of up to $1.5 billion and a premium of approximately 215% to Poseida’s closing share price on November 25, 2024. Cooley previously represented Poseida in its initial public offering, equity and debt transactions, and collaboration agreements, including its collaboration agreement with Roche.
Related contacts
Related Practices & Industries
Avid Bioservices Announces $1.1 Billion Acquisition by GHO Capital Partners and Ampersand Capital Partners
November 6, 2024
Cooley advised Avid Bioservices (Nasdaq: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, on its definitive merger agreement to be acquired by funds managed by GHO Capital Partners and Ampersand Capital Partners in an all-cash transaction valued at approximately $1.1 billion.
Related contacts
Related Practices & Industries
Tempus Announces $600 Million Acquisition of Ambry Genetics
November 4, 2024
Cooley advised Tempus AI (Nasdaq: TEM), a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, on its agreement to acquire Ambry Genetics, a company focusing on genetic testing that aims to improve health by understanding the relationship between genetics and disease.
Related contacts
Battery Ventures-Backed PageUp To Be Acquired by EQT Partners
October 31, 2024
Cooley advised Battery Ventures, a global, technology-focused investment firm, and PageUp Group, a human resources and talent software company that had been majority owned by Battery, on the sale of PageUp to EQT Group.
Related contacts
Related Practices & Industries
Related news and events
Poseida Therapeutics Announces Agreement to Be Acquired by Roche for up to $1.5 Billion
Kura Oncology Announces Global Strategic Collaboration With Kyowa Kirin
Admissions and credentials
California
Massachusetts
Rankings and accolades
Chambers USA: Tax – California: Southern (2020 – 2024)
Chambers USA: Litigation: Securities – California (2020 – 2023)
Todd is 'an exceptional tax attorney' who 'communicates difficult matters in a very clear way,' and is 'an authority and skilled influencer who achieves outsized outcomes.'
Chambers USA 2022